Literature DB >> 22020370

HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis.

Jelena Radojicic1, Apostolos Zaravinos, Demetrios A Spandidos.   

Abstract

Esophageal squamous-cell carcinoma (ESCC) is an invasive neoplastic disease generally associated with poor survival rates. The incidence of ESCC is characterized by marked geographic variation, with highest rates noted in developing Southeastern African, Central and Eastern Asian countries. In the developed Western European and North American regions where there is a low disease incidence, heavy alcohol and cigarette consumption constitute major risk factors. The toxic effects of both these risk factors cause chronic irritation and inflammation of the esophageal mucosa, while at the cellular level they further confer mutagenic effects by the activation of oncogenes (e.g., RAS mutations), inhibition of tumor-suppressor genes, and profound DNA damage. Viral infections, particularly with human papillomavirus, may activate specific antiapoptotic, proliferative and malignant cellular responses that may be intensified in combination with the effects of alcohol and tobacco. In countries with a high ESCC incidence, low socioeconomic status and an inadequate diet of poorly preserved food are combined with basic nutritional deficiencies and inadequate medical treatment. These conditions are favorable to the above-mentioned risk factors implicated in ESCC development, which may be present and/or habitually used in certain populations. New perspectives in epidemiological studies of ESCC development and its risk factors allow genome-wide research involving specific environments and habits. Such research should consist of adequately large and representative samples, should use newly designed informative genetic markers, and apply genomic variation analysis of the functional transcripts involved in malignant cell cycle regulation and neoplastic transformation in the multi-step process of ESCC carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22020370     DOI: 10.5301/JBM.2011.8737

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  15 in total

1.  Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.

Authors:  Guoren Zhou; Jinjun Ye; Lei Sun; Zhi Zhang; Jifeng Feng
Journal:  J Mol Histol       Date:  2016-04-15       Impact factor: 2.611

2.  Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma.

Authors:  Shu Zhang; Xiaojing Yang; Hui Shi; Mei Li; Qun Xue; Hanru Ren; Li Yao; Xueyu Chen; Jianguo Zhang; Huijie Wang
Journal:  J Mol Histol       Date:  2014-01-30       Impact factor: 2.611

3.  Expression and clinical role of NF45 as a novel cell cycle protein in esophageal squamous cell carcinoma (ESCC).

Authors:  Sujie Ni; Junya Zhu; Jianguo Zhang; Shu Zhang; Mei Li; Runzhou Ni; Jinxia Liu; Huiyuan Qiu; Wenjuan Chen; Huijie Wang; Weijian Guo
Journal:  Tumour Biol       Date:  2014-10-08

Review 4.  The tumor microenvironment in esophageal cancer.

Authors:  E W Lin; T A Karakasheva; P D Hicks; A J Bass; A K Rustgi
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

5.  Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma.

Authors:  Peng Sun; Cui Chen; Fei Zhang; Hang Yang; Xi-Wen Bi; Xin An; Feng-Hua Wang; Wen-Qi Jiang
Journal:  Onco Targets Ther       Date:  2016-07-13       Impact factor: 4.147

6.  Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.

Authors:  Xiaobin Cui; Zhimin Zhao; Dong Liu; Tao Guo; Su Li; Jianming Hu; Chunxia Liu; Lan Yang; Yuwen Cao; Jinfang Jiang; Weihua Liang; Wei Liu; Shugang Li; Lianghai Wang; Lidong Wang; Wenyi Gu; Chuanyue Wu; Yunzhao Chen; Feng Li
Journal:  J Exp Clin Cancer Res       Date:  2014-02-17

7.  High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagus.

Authors:  Zhimin Zhang; Hualiang Xiao; Fei Xie; Hui Zhang; Chuan Chen; He Xiao; Zhenzhou Yang; Dong Wang; Zengpeng Li; Ge Wang
Journal:  BMC Cancer       Date:  2014-01-14       Impact factor: 4.430

8.  KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.

Authors:  Sabine Heublein; Katinka Grasse; Harald Hessel; Alexander Burges; Miriam Lenhard; Jutta Engel; Thomas Kirchner; Udo Jeschke; Doris Mayr
Journal:  BMC Cancer       Date:  2013-10-18       Impact factor: 4.430

9.  Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.

Authors:  Xin Zheng; Shan Xing; Xiao-Min Liu; Wen Liu; Dan Liu; Pei-Dong Chi; Hao Chen; Shu-Qin Dai; Qian Zhong; Mu-Sheng Zeng; Wan-Li Liu
Journal:  BMC Cancer       Date:  2014-07-07       Impact factor: 4.430

Review 10.  An updated overview of HPV-associated head and neck carcinomas.

Authors:  Apostolos Zaravinos
Journal:  Oncotarget       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.